Cargando…

Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA

Detalles Bibliográficos
Autores principales:	Zhao, Xinmin, Wu, Xianghua, Wang, Huijie, Lai, Songtao, Wang, Jialei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518037/ https://www.ncbi.nlm.nih.gov/pubmed/37750088 http://dx.doi.org/10.1002/mco2.385

Ejemplares similares

Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
por: Zhao, Xinmin, et al.
Publicado: (2023)

Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)

Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
por: Berezhnoy, Alexey, et al.
Publicado: (2012)

Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy
por: Nguyen, Juliane, et al.
Publicado: (2008)

Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
por: Hu, Zhihuang, et al.
Publicado: (2022)

Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
por: Kruspe, Sven, et al.
Publicado: (2017)

USP10 Targeted Self-Deliverable siRNA to Prevent Scarring in the Cornea
por: Boumil, Edward F., et al.
Publicado: (2020)

A Universal Protein Tag for Delivery of SiRNA-Aptamer Chimeras
por: Liu, Hong Yan, et al.
Publicado: (2013)

Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer
por: Dinis Ano Bom, Ana Paula, et al.
Publicado: (2019)

Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer
por: Liu, Zhe, et al.
Publicado: (2023)

Facilitated Tau Degradation by USP14 Aptamers via Enhanced Proteasome Activity
por: Lee, Jung Hoon, et al.
Publicado: (2015)

Research progress on siRNA delivery with nonviral carriers
por: Gao, Yan, et al.
Publicado: (2011)

Phosphorus Dendrimers as Carriers of siRNA—Characterisation of Dendriplexes
por: Ferenc, Malgorzata, et al.
Publicado: (2013)

Preparation and Characterization of Functionalized Graphene Oxide Carrier for siRNA Delivery
por: Li, Jing, et al.
Publicado: (2018)

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer
por: Subramanian, Nithya, et al.
Publicado: (2015)

Redox-Sensitive Gelatin/Silica-Aptamer Nanogels for Targeted siRNA Delivery
por: Zhao, Xueqin, et al.
Publicado: (2019)

Screening of efficient siRNA carriers in a library of surface-engineered dendrimers
por: Liu, Hongmei, et al.
Publicado: (2016)

PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
por: Zhao, Yi, et al.
Publicado: (2016)

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017)

Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1
por: Zhou, Jiehua, et al.
Publicado: (2018)

Rabies Prophylactic and Treatment Options: An In Vitro Study of siRNA- and Aptamer-Based Therapeutics
por: Scott, Terence Peter, et al.
Publicado: (2021)

Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review
por: Wu, Jiangyu, et al.
Publicado: (2013)

Exosomes are natural carriers of exogenous siRNA to human cells in vitro
por: Shtam, Tatyana A, et al.
Publicado: (2013)

Aptamer-siRNA chimera and gold nanoparticle modified collagen membrane for the treatment of malignant pleural effusion
por: Chen, Wen, et al.
Publicado: (2022)

Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy
por: Wang, Fen, et al.
Publicado: (2018)

Insights on prospects of nano-siRNA based approaches in treatment of Cancer
por: Goyal, Rajat, et al.
Publicado: (2022)

Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras
por: Nachreiner, Inga, et al.
Publicado: (2019)

Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Khanali, Javad, et al.
Publicado: (2021)

Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2011)

A Bifurcated Proteoglycan Binding Small Molecule Carrier for siRNA Delivery
por: Gooding, Matt, et al.
Publicado: (2014)

Silver Nanoparticles Surface-Modified with Carbosilane Dendrons as Carriers of Anticancer siRNA
por: Pędziwiatr-Werbicka, Elżbieta, et al.
Publicado: (2020)

Effective carrier-free gene-silencing activity of cholesterol-modified siRNAs
por: Salim, Lidya, et al.
Publicado: (2018)

Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group
por: Petrova, Natalya S., et al.
Publicado: (2012)

Delivery of chemo-sensitizing siRNAs to HER2(+)-breast cancer cells using RNA aptamers
por: Thiel, Kristina W., et al.
Publicado: (2012)

A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma
por: Luo, Zhiguo, et al.
Publicado: (2015)

Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells
por: Zhou, Yanghao, et al.
Publicado: (2021)

The optimal timing and courses of bevacizumab added to chemotherapy for non-squamous non-small cell lung cancer: revelations from the real-world experience in a single Chinese cancer center
por: Long, Qianqian, et al.
Publicado: (2020)

Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14
por: IMAI, Kohzoh, et al.
Publicado: (2022)

Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for DNA, shRNA and siRNA
por: Arima, Hidetoshi, et al.
Publicado: (2012)

Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation
por: Chen, Zhihang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b0pmkla6s5021ra945g2qeertd